2019
Assessment of Striatal Dopamine Transporter Binding in Individuals With Major Depressive Disorder
Pizzagalli D, Berretta S, Wooten D, Goer F, Pilobello K, Kumar P, Murray L, Beltzer M, Boyer-Boiteau A, Alpert N, Fakhri G, Mechawar N, Vitaliano G, Turecki G, Normandin M. Assessment of Striatal Dopamine Transporter Binding in Individuals With Major Depressive Disorder. JAMA Psychiatry 2019, 76: 854-861. PMID: 31042280, PMCID: PMC6495358, DOI: 10.1001/jamapsychiatry.2019.0801.Peer-Reviewed Original ResearchConceptsMajor depressive disorderDA transporter availabilityVentral tegmental areaDA transporterDAT availabilityTegmental areaDepressive disorderDA signalingPositron emission tomographyDAT expressionMcLean HospitalHealthy controlsMajor depressive disorder groupsNumbers of depressive episodesStriatal dopamine transporter bindingDA transporter levelsLevels of DAT expressionStriatal DAT expressionStriatal DAT availabilityDA transporter densityDAT binding potentialDopamine transporter bindingOlder healthy controlsMesolimbic pathwayDA clearance
2012
Parametric imaging with Bayesian priors: A validation study with 11C-Altropane PET
Fang Y, Fakhri G, Becker J, Alpert N. Parametric imaging with Bayesian priors: A validation study with 11C-Altropane PET. NeuroImage 2012, 61: 131-138. PMID: 22425668, DOI: 10.1016/j.neuroimage.2012.03.003.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAlgorithmsBayes TheoremBiasCarbon RadioisotopesCocaineData Interpretation, StatisticalFemaleHumansImage Processing, Computer-AssistedKineticsLeast-Squares AnalysisMaleMiddle AgedNeuroimagingNonlinear DynamicsNormal DistributionPopulationPositron-Emission TomographyRadiopharmaceuticalsReference ValuesSample SizeYoung Adult